VISEN PHARMA's stabilization period ends, and the over-allotment option expires

AASTOCKS
2025.04.21 11:51

VISEN PHARMA-B (02561.HK) announced that the stabilization period related to the global offering ended on April 17. During this period, the stabilization agent Morgan Stanley Asia consecutively purchased a total of 1.7077 million shares, with prices ranging from HKD 58.35 to HKD 68.8 per share. The last purchase date was March 25, at a price of HKD 60. In addition, the overallotment option was not exercised and has expired on April 17

Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.